ArticleJournal of pharmaceutical analysis2025

Isovalerylspiramycin I alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2 (NUBP2)-vascular non-inflammatory molecule-1 (VNN1) pathway.

Na Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.